Filing Details

Accession Number:
0001206386-18-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-13 16:19:26
Reporting Period:
2018-07-11
Accepted Time:
2018-07-13 16:19:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206386 M Richard Marsh 320 Wakara Way
Salt Lake City UT 84108
E.v.p., General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-11 30,672 $23.11 154,869 No 4 M Direct
Common Stock Disposition 2018-07-11 30,672 $44.00 124,197 No 4 S Direct
Common Stock Acquisiton 2018-07-11 40,000 $23.11 164,197 No 4 M Direct
Common Stock Disposition 2018-07-11 40,000 $42.02 124,197 No 4 S Direct
Common Stock Disposition 2018-07-11 7,623 $0.00 116,574 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 G Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-07-11 30,672 $0.00 30,672 $23.11
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-07-11 40,000 $0.00 40,000 $23.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2013-03-03 2020-03-03 No 4 M Direct
0 2014-03-03 2020-03-03 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.